"Inhaler Discontinuation in January Leaves Asthma Patients Seeking Alternatives"

Flovent, a widely used asthma inhaler, is being discontinued in the US, with a generic version set to replace it. However, there are concerns about insurance coverage for the generic, potential distribution issues, and the impact on patients, particularly during cold and flu season. The discontinuation is attributed to changes in Medicaid rebates and the drug's price increase over the years. Doctors are advising patients to prepare for the transition and seek alternatives if necessary.